AstraZeneca

Surprise: AstraZeneca's $39B Alexion buy clears a newly vigilant FTC without a hitch
Surprise: AstraZeneca's $39B Alexion buy clears a newly vigilant FTC without a hitch
Fierce Pharma
AstraZeneca
Alexion
M&A
FTC
Flag link:
Europe won't renew AstraZeneca, Johnson & Johnson COVID-19 vaccine contracts next year: report
Europe won't renew AstraZeneca, Johnson & Johnson COVID-19 vaccine contracts next year: report
Fierce Pharma
Europe
JNJ
AstraZeneca
COVID-19
vaccines
Flag link:
9 things to know about the J&J, AstraZeneca COVID-19 vaccines & blood clots
9 things to know about the J&J, AstraZeneca COVID-19 vaccines & blood clots
Beckers Hospital Review
JNJ
AstraZeneca
COVID-19
vaccines
blood clots
Flag link:
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
Marketwatch
vaccines
COVID-19
Moderna Therapeutics
Novavax
AstraZeneca
Pfizer
BioNTech
clinical trials
Flag link:
AZ aims at Pfizer, GSK with potential new PARP cancer drug
AZ aims at Pfizer, GSK with potential new PARP cancer drug
Pharmaforum
AstraZeneca
PARP inhibitors
Pfizer
GSK
cancer
Lynparza
Flag link:
Quiet times return for biopharma takeouts
Quiet times return for biopharma takeouts
EP Vantage
M&A
Alexion
Amgen
AstraZeneca
Biogen
Five Prime Therapeutics
Gilead Sciences
GW Pharma
Horizon Therapeutics
Immunomedics
Jazz Pharmaceutical
Kymab
Merck
Pandion
Sanofi
Viela Bio
Flag link:
CEOs of COVID-19 Vaccine Makers See Boost in Salaries
CEOs of COVID-19 Vaccine Makers See Boost in Salaries
BioSpace
Pharma CEOs
COVID-19
executive pay
Albert Bourla
Pfizer
Ugur Sahin
BioNTech
Stephane Bancel
Moderna Therapeutics
Alex Gorsky
JNJ
Pascal Soriot
AstraZeneca
Flag link:
AZ showcases data for next-generation PARP inhibitor AZD5305
AZ showcases data for next-generation PARP inhibitor AZD5305
PM Live
AstraZeneca
AZD5305
Lynparza
AACR
Flag link:
AstraZeneca’s Farxiga fails phase 3 COVID-19 test
AstraZeneca’s Farxiga fails phase 3 COVID-19 test
Pharmaforum
AstraZeneca
diabetes
heart failure
Farxiga
COVID-19
clinical trials
Flag link:
AstraZeneca COVID-19 vaccine linked to rare blood clots, EMA official says, but benefits still outweigh risks
AstraZeneca COVID-19 vaccine linked to rare blood clots, EMA official says, but benefits still outweigh risks
Fierce Pharma
AstraZeneca
EMA
vaccines
COVID-19
blood clots
Flag link:
AstraZeneca is forced to scout for new COVID-19 vaccine manufacturing partner, dealing the launch another setback
AstraZeneca is forced to scout for new COVID-19 vaccine manufacturing partner, dealing the launch another setback
Fierce Pharma
AstraZeneca
vaccines
COVID-19
drug manufacturing
Flag link:
TikTok famous? Pfizer, Moderna, J&J and AZ shoutouts on social media boost vaccine credibility—and pharmas' image
TikTok famous? Pfizer, Moderna, J&J and AZ shoutouts on social media boost vaccine credibility—and pharmas' image
Fierce Pharma
Pfizer
Moderna Therapeutics
JNJ
AstraZeneca
social media
vaccines
TikTok
COVID-19
Flag link:
5 FDA approval decisions to watch in the second quarter
5 FDA approval decisions to watch in the second quarter
BioPharma Dive
FDA
Biogen
aducanumab
Acadia Pharmaceuticals
pimavanserin
AstraZeneca
vaccines
COVID-19
Sanofi
Avalglucosidase alfa
Pfizer
pneumococcal disease
Flag link:
GlaxoSmithKline, Novavax team up on COVID vaccine production in U.K., helping reduce dependence on AZ shot
GlaxoSmithKline, Novavax team up on COVID vaccine production in U.K., helping reduce dependence on AZ shot
Fierce Pharma
GSK
Novavax
vaccines
COVID-19
drug manufacturing
AstraZeneca
UK
Flag link:
AstraZeneca partner takes nasal COVID-19 vaccine into phase 1
AstraZeneca partner takes nasal COVID-19 vaccine into phase 1
Fierce Pharma
University of Oxford
AstraZeneca
vaccines
COVID-19
intranasal vaccines
Flag link:
AstraZeneca updates Covid-19 vaccine data, now showing 76% efficacy
AstraZeneca updates Covid-19 vaccine data, now showing 76% efficacy
MedCity News
AstraZeneca
vaccines
COVID-19
Flag link:
AstraZeneca hits out against ‘inaccurate statements’ on COVID-19 vaccine supplies from Italian plant
AstraZeneca hits out against ‘inaccurate statements’ on COVID-19 vaccine supplies from Italian plant
Biopharma Reporter
AstraZeneca
vaccines
COVID-19
Italy
drug manufacturing
COVAX
Europe
Flag link:
Pushing back against U.S. health officials, AstraZeneca says new analysis confirms efficacy of its Covid-19 vaccine
Pushing back against U.S. health officials, AstraZeneca says new analysis confirms efficacy of its Covid-19 vaccine
Stat
AstraZeneca
vaccines
COVID-19
Flag link:
The saga of mishaps and miscommunications overshadowing AstraZeneca’s Covid vaccine
The saga of mishaps and miscommunications overshadowing AstraZeneca’s Covid vaccine
Stat
AstraZeneca
vaccines
COVID-19
Flag link:
AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions
AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions
MedCity News
AstraZeneca
NIH
vaccines
COVID-19
Flag link:

Pages